Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients
Conditions
- Non Small Cell Lung Cancer
Interventions
- BIOLOGICAL: Sintilimab
- DRUG: Metformin Hydrochloride
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators